In the news | 2nd Aug 2022
Approaching the BioPharma data lifecycle in an integrated manner
Advances in digital technology offer an attractive solution to biopharmaceutical companies looking to deliver a new generation of increasingly complex therapies. While artificial intelligence and automation such as the Industry 4.0 movement have the potential to reduce time and cost, modernized data governance is essential to ensure a solid foundation of data integrity and regulatory compliance to meet these objectives.
Read about an integrated approach to the BioPharma data lifecycle in this article by Scott Weiss, Vice President of Business Development and Open Innovation, IDBS, published in PharmTech.com.
European Biomanufacturing Summit 2023
Come and join us at booth 130 in Amsterdam, to learn how an innovative tech transfer approach can revolutionize drug manufacturing in the pharmaceutical industry.
IDBS events roundup: Q1 highlights and Q2 events
IDBS associates had the opportunity to attend some events in Q1 and attendees were eager to see, hear and learn more about what’s happening in the industry.
How to improve time-to-value using GxP computer systems
Explore the benefits of GxP computer systems to improve time-to-value so that companies can speed up the development and manufacture of life-saving drugs.
New process definition capabilities in PIMS enhance quality assurance and validation for pharma manufacturers
IDBS reveals new process definition-handling capabilities in PIMS 5.0, which enhance quality assurance and validation for pharma manufacturers.